Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco diabetes management program finds 3,000 at-risk patients via self-assessment questionnaire.

Executive Summary

MEDCO DIABETES MANAGEMENT SUPPORT PROGRAM FINDS 3,000 AT-RISK PATIENTS via a self-assessment questionnaire sent to more than 105,000 diabetics at the end of 1994, Medco Associate Director for Health Strategies & Programs Martha Sutphin told a Zitter Group conference in San Francisco July 20-21. Sutphin said that of the 11,000 patients who responded to the questionnaire, about 3,000 indicated they were at risk when they answered "yes" to the first nine of 36 questions. The company followed up on at-risk patients by contacting physicians to see if their patients came for appointments and if the physician used the questionnaire.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel